Clinical Trial

FDG-PET in the Diagnosis of Autoimmune Encephalitis

Study acronym: PEA
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this retrospective observational study is to compare brain fluorodeoxyglucose-positron emission tomography (FDG-PET) of patients with autoimmune encephalitis, normal controls and patients with Alzheimer's disease (AD). The main question it aims to answer is: •is there a specific pattern of brain metabolism in patients with autoimmune encephalitis Participants data and images will be retrospectively collected from hospital records, and FDG-PET images will be analyzed by means of statistical parametric mapping (SPM). Controls will be selected from validated public databases.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-08-25; most recent amendment 2026-03-23.
Trial Details
NCT Number NCT06019975
Lead Sponsor University of Milano Bicocca
Conditions Autoimmune Encephalitis
Enrollment 90 participants
Start Date 2023-03-01
Primary Completion 2027-03-31 (estimated)
Study Completion 2027-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-24